Recombinant Full Length Human DNMT3A Protein, C-Flag-tagged

• Cat.No.: DNMT3A-1122HFL
• Product Overview: Recombinant Full Length Human DNMT3A Protein, fused to Flag-tag at C-terminus, was expressed in Mammalian cells.

Specification

• Description: CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated.
• Source: Mammalian cells
• Species: Human
• Tag: Flag
• Form: 25 mM Tris HCl, pH 7.3, 100 mM glycine, 10% glycerol.
• Molecular Mass: 101.7 kDa
• AA Sequence: MPAMPSSGPGDTSSSAAEREEDRKD GEEQEEPRGKEERQEPSTTARKVGR PGRKRKHPPVESGDTPKDPA VISKSPSMAQDSGASELLPNGDLEK RSEPQPEEGSPAGGQKGGAPAEGEG AAETLPEASRAVENGCCTPK EGRGAPAEAGKEQKETNIESMKMEG SRGRLRGGLGWESSLRQRPMPRLTF QAGDPYYISKRKRDEWLARW KREAEKKAKVIAGMNAVEENQGPGE SQKVEEASPPAVQQPTDPASPTVAT TPEPVGSDAGDKNATKAGDD EPEYEDGRGFGIGELVWGKLRGFSW WPGRIVSWWMTGRSRAAEGTRWVMW FGDGKFSVVCVEKLMPLSSF CSAFHQATYNKQPMYRKAIYEVLQV ASSRAGKLFPVCHDSDESDTAKAVE VQNKPMIEWALGGFQPSGPK GLEPPEEEKNPYKEVYTDMWVEPEA AAYAPPPPAKKPRKSTAEKPKVKEI IDERTRERLVYEVRQKCRNI EDICISCGSLNVTLEHPLFVGGMCQ NCKNCFLECAYQYDDDGYQSYCTIC CGGREVLMCGNNNCCRCFCV ECVDLLVGPGAAQAAIKEDPWNCYM CGHKGTYGLLRRREDWPSRLQMFFA NNHDQEFDPPKVYPPVPAEK RKPIRVLSLFDGIATGLLVLKDLGI QVDRYIASEVCEDSITVGMVRHQGK IMYVGDVRSVTQKHIQEWGP FDLVIGGSPCNDLSIVNPARKGLYE GTGRLFFEFYRLLHDARPKEGDDRP FFWLFENVVAMGVSDKRDIS RFLESNPVMIDAKEVSAAHRARYFW GNLPGMNRPLASTVNDKLELQECLE HGRIAKFSKVRTITTRSNSI KQGKDQHFPVFMNEKEDILWCTEME RVFGFPVHYTDVSNMSRLARQRLLG RSWSVPVIRHLFAPLKEYFA
  CVTRTRPLEQKLISEEDLAANDILD YKDDDDKV
• Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining.
• Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.
• Storage: Store at -80 centigrade.
• Concentration: >50 ug/mL as determined by microplate BCA method.
• Preparation: Recombinant protein was captured through anti-DDK affinity column followed by conventional chromatography steps.
• Protein Families: Druggable Genome
• Protein Pathways: Cysteine and methionine metabolism, Metabolic pathways

Gene Information

• Gene Name: DNMT3A DNA methyltransferase 3 alpha [ Homo sapiens (human) ]
• Official Symbol: DNMT3A
• Synonyms: TBRS; HESJAS; DNMT3A2; M.HsaIIIA
• Gene ID: 1788
• mRNA Refseq: NM_022552.5
• Protein Refseq: NP_072046.2
• MIM: 602769
• UniProt ID: Q9Y6K1

Reviews

11/17/2022

Its exceptional characteristics, coupled with the manufacturer's commitment to customer satisfaction, ensure that I can pursue my scientific investigations with confidence and success.

09/07/2022

Its consistent performance and reproducibility have been praised by scientists who have employed it in their studies, with many reporting outstanding results and a high level of satisfaction.

08/20/2017

This level of support becomes invaluable, allowing researchers to focus on their scientific objectives while receiving expert guidance alongside.

Q&As

Can DNMT3A protein be used as a biomarker for cancer diagnosis?

DNMT3A mutations can serve as biomarkers for certain cancers, aiding in the diagnosis and classification of hematologic malignancies.

How does DNMT3A impact normal cellular function?

DNMT3A is essential for normal DNA methylation patterns during development and differentiation, influencing gene expression and cellular function.

Can DNMT3A-targeted therapies have off-target effects?

Like many targeted therapies, DNMT3A-targeted treatments may have off-target effects, and their specificity is an area of active research.

Are there diagnostic tests for detecting DNMT3A mutations?

Yes, molecular diagnostic tests, such as DNA sequencing, can identify DNMT3A mutations in cancer cells.

How does DNMT3A contribute to epigenetic changes in cancer cells?

DNMT3A mutations lead to abnormal DNA methylation patterns, contributing to altered gene expression and promoting cancer development.